KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Cvs Health (CVS) Shares Outstanding (2016 - 2025)

Cvs Health's Shares Outstanding history spans 17 years, with the latest figure at $1.3 billion for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding fell 28.52% year-over-year to $1.3 billion, compared with a TTM value of $1.3 billion through Dec 2025, down 28.52%, and an annual FY2025 reading of $1.3 billion, down 28.52% over the prior year.
  • Shares Outstanding for Q4 2025 was $1.3 billion at Cvs Health, roughly flat from $1.3 billion in the prior quarter.
  • The five-year high for Shares Outstanding was $1.8 billion in Q2 2025, with the low at $1.3 billion in Q3 2025.
  • Average Shares Outstanding over 5 years is $1.7 billion, with a median of $1.8 billion recorded in 2022.
  • Year-over-year, Shares Outstanding skyrocketed 512.06% in 2021 and then dropped 28.53% in 2025.
  • Tracing CVS's Shares Outstanding over 5 years: stood at $1.7 billion in 2021, then grew by 0.8% to $1.8 billion in 2022, then grew by 0.57% to $1.8 billion in 2023, then increased by 0.57% to $1.8 billion in 2024, then fell by 28.52% to $1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for CVS's Shares Outstanding are $1.3 billion (Q4 2025), $1.3 billion (Q3 2025), and $1.8 billion (Q2 2025).